CLASS I Drug recall · Reported 12 Feb 2014 · FDA Enforcement Report

Cefepime for Injection USP and Dextrose Injection recalled

B. Braun Medical is recalling Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System in, distributed nationwide in the US. The recall was initiated on 15 Oct 2013 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot H3A744, Exp 01/15
NDC0264-3193, 0264-3195
Quantity recalled18,936 Containers

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1054-2014
FDA event ID
66497
Recalling firm
B. Braun Medical, Irvine, CA
Manufacturer
B. Braun Medical Inc.
Classification
Class I
Status
Terminated
Recall initiated
15 Oct 2013
FDA classified
31 Jan 2014
Reported
12 Feb 2014
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Particulate Matter

Timeline

15 Oct 2013Recall initiated by company
31 Jan 2014Classified by FDA+108 days
12 Feb 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.

Product as listed by the FDA

Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Single Dose, Sterile/Non pyrogenic, Rx Only, B Braun Medical Inc., NDC 0264-3193-11

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.

Which lots are affected?

Lot H3A744, Exp 01/15

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from B. Braun Medical

All 447

Other Cefepime recalls

All 11